Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora Peyvandi

Showing results (261-270 of 610) with videos related to

Pageof 61
Sort By:
Research and Practice in Thrombosis and Haemostasis|December 1, 2025
Deep molecular modeling and mechanistic insights into type 2A von Willebrand disease with von Willebrand factor A2 domain mutationsOmid Seidizadeh, Luca Mollica, Davide Giana, et al.
Therapeutic Advances in Hematology|March 16, 2026
An analysis of attitudes toward gene therapy in people with severe hemophilia in Germany, a survey-based cross-sectional studySvetlana Babayeva, Aida Peyvandi, Christian Schepperle, et al.
Thrombosis Research|August 30, 2011
B and T lymphocytes in acquired thrombotic thrombocytopenic purpura during disease remissionMariagabriella Mariani, Andrea Cairo, Roberta Palla, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 21, 2015
Mediterranean spotted fever and hearing impairment: a rare complicationRaffaella Rossio, Valeria Conalbi, Valentina Castagna, et al.
Haematologica|September 2, 2004
Molecular characterization of a factor VII deficient patient supports the importance of the second epidermal growth factor-like domainGiovanna D'Andrea, Anna Bossone, Maria Rosaria Lupone, et al.
Thrombosis Research|November 6, 2019
The features of acquired thrombotic thrombocytopenic purpura occurring at advanced agePasquale Agosti, Ilaria Mancini, Andrea Artoni, et al.
Journal of Thrombosis and Haemostasis : JTH|December 28, 2020
Characterization of the neutralizing anti-emicizumab antibody in a patient with hemophilia A and inhibitorCarla Valsecchi, Marco Gobbi, Marten Beeg, et al.
Thrombosis Research|January 8, 2014
A recurrent Gly43Asp substitution in coagulation Factor X rigidifies its catalytic pocket and impairs catalytic activity and intracellular traffickingMarzia Menegatti, Anna Vangone, Roberta Palla, et al.
Molecular Genetics & Genomic Medicine|April 12, 2016
A recurrent F8 mutation (c.6046C>T) causing hemophilia A in 8% of northern Italian patients: evidence for a founder effectIsabella Garagiola, Sabrina Seregni, Mimosa Mortarino, et al.
Haematologica|November 25, 2017
Clustered <i>F8</i> missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activityIrving Donadon, John H McVey, Isabella Garagiola, et al.
Pageof 61

Showing results (261-270 of 610) with videos related to

Sort By:
Pageof 61
Research and Practice in Thrombosis and Haemostasis|December 1, 2025
Deep molecular modeling and mechanistic insights into type 2A von Willebrand disease with von Willebrand factor A2 domain mutationsOmid Seidizadeh, Luca Mollica, Davide Giana, et al.
Therapeutic Advances in Hematology|March 16, 2026
An analysis of attitudes toward gene therapy in people with severe hemophilia in Germany, a survey-based cross-sectional studySvetlana Babayeva, Aida Peyvandi, Christian Schepperle, et al.
Thrombosis Research|August 30, 2011
B and T lymphocytes in acquired thrombotic thrombocytopenic purpura during disease remissionMariagabriella Mariani, Andrea Cairo, Roberta Palla, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 21, 2015
Mediterranean spotted fever and hearing impairment: a rare complicationRaffaella Rossio, Valeria Conalbi, Valentina Castagna, et al.
Haematologica|September 2, 2004
Molecular characterization of a factor VII deficient patient supports the importance of the second epidermal growth factor-like domainGiovanna D'Andrea, Anna Bossone, Maria Rosaria Lupone, et al.
Thrombosis Research|November 6, 2019
The features of acquired thrombotic thrombocytopenic purpura occurring at advanced agePasquale Agosti, Ilaria Mancini, Andrea Artoni, et al.
Journal of Thrombosis and Haemostasis : JTH|December 28, 2020
Characterization of the neutralizing anti-emicizumab antibody in a patient with hemophilia A and inhibitorCarla Valsecchi, Marco Gobbi, Marten Beeg, et al.
Thrombosis Research|January 8, 2014
A recurrent Gly43Asp substitution in coagulation Factor X rigidifies its catalytic pocket and impairs catalytic activity and intracellular traffickingMarzia Menegatti, Anna Vangone, Roberta Palla, et al.
Molecular Genetics & Genomic Medicine|April 12, 2016
A recurrent F8 mutation (c.6046C>T) causing hemophilia A in 8% of northern Italian patients: evidence for a founder effectIsabella Garagiola, Sabrina Seregni, Mimosa Mortarino, et al.
Haematologica|November 25, 2017
Clustered <i>F8</i> missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activityIrving Donadon, John H McVey, Isabella Garagiola, et al.
Pageof 61